» Articles » PMID: 12501152

Dosing Patterns for Continuous Renal Replacement Therapy at a Large Academic Medical Center in the United States

Overview
Journal J Crit Care
Specialty Critical Care
Date 2002 Dec 26
PMID 12501152
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We sought to retrospectively review the dosing patterns of continuous renal replacement therapy (CRRT) in patients with acute renal failure (ARF) and determine their actual delivered dosage of CRRT.

Materials And Methods: Computerized records of patients (n = 115) who received CRRT for ARF at a single, large, academic, tertiary care hospital from September 1, 1999 through August 31, 2000 were reviewed. The delivered dose of CRRT for each patient/day was calculated from the hourly effluent flow rate, the patient's weight, and the duration (in hours) of CRRT for that day. A mean effluent flow rate (in L/h) for each patient was then calculated.

Results: The average number of hours/day on CRRT was 16.1 +/- 3.53 (mean +/- SD), with a mean flow rate (averaged over 24 h) of 1.36 +/- 0.31 L/h. The mean CRRT dose prescribed for these patients was 24.46 +/- 6.73 mL/Kg/h, but the mean dose delivered was only 16.55 +/- 5.41 mL/Kg/h (68% of the prescribed dose, P <.000001).

Conclusions: Many patients are prescribed low doses of CRRT. Furthermore, the dose delivered is considerably lower than that prescribed. Methods and procedures to extend CRRT system life may improve the dose delivery.

Citing Articles

Protocolized Regional Citrate Anticoagulation during Continuous Renal Replacement Therapy: A Single Center Experience.

Pachisia A, Kumar G, Harne R, Jagadeesh K, Patel S, Pal D Indian J Crit Care Med. 2024; 28(9):859-865.

PMID: 39360210 PMC: 11443258. DOI: 10.5005/jp-journals-10071-24797.


Programs and processes for advancing pediatric acute kidney support therapy in hospitalized and critically ill children: a report from the 26th Acute Disease Quality Initiative (ADQI) consensus conference.

Neumayr T, Bayrakci B, Chanchlani R, Deep A, Morgan J, Arikan A Pediatr Nephrol. 2023; 39(3):993-1004.

PMID: 37930418 PMC: 10817827. DOI: 10.1007/s00467-023-06186-4.


The influence of continuous renal replacement therapy on 1,3-β-d-glucan levels in critically ill patients: a single-center retrospective propensity score study.

Cabanilla M, Briski M, Bruss Z, Saa L, Vasquez P, Rodriguez C Ren Fail. 2023; 45(2):2255680.

PMID: 37781748 PMC: 10547441. DOI: 10.1080/0886022X.2023.2255680.


Anticoagulation in renal replacement therapies: Why heparin should be abandoned in critical ill patients?.

Musalem P, Pedreros-Rosales C, Muller-Ortiz H Int Urol Nephrol. 2023; 56(4):1383-1393.

PMID: 37755609 DOI: 10.1007/s11255-023-03805-9.


ISCCM Guidelines on Acute Kidney Injury and Renal Replacement Therapy.

Mishra R, Sodhi K, Prakash K, Tyagi N, Chanchalani G, Annigeri R Indian J Crit Care Med. 2023; 26(Suppl 2):S13-S42.

PMID: 36896356 PMC: 9989875. DOI: 10.5005/jp-journals-10071-24109.